Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytomegalovirus Infection Reactivation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01326273
What this trial is testing

Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation

Who this might be right for
CMV ReactivationAllogeneic Stem Cell TransplantationAutologous CMV Specific CD8+ T Cells
Imperial College London
Early research (Phase 1)Study completedNCT04153279
What this trial is testing

CMV-TCR-T Cells for CM Virus Infection After HSCT

Who this might be right for
CMV Infection or Reactivation After Allogenic HSCT
Hebei Yanda Ludaopei Hospital 17
Not applicableNot Yet RecruitingNCT07210242
What this trial is testing

HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR

Who this might be right for
Cytomegalovirus InfectionsHematopoietic Stem Cell TransplantationVirus Reactivation+1 more
Ting YANG 300
Not applicableUnknownNCT02874157
What this trial is testing

Evaluation of Methods for Diagnosis of Cytomegalovirus Pneumonia in Mechanically Ventilated Patient

Who this might be right for
CMV Reactivation Diagnosis in ICU Patient
Assistance Publique Hopitaux De Marseille 450
Testing effectiveness (Phase 2)Study completedNCT01503918
What this trial is testing

Cytomegalovirus Control in Critical Care

Who this might be right for
Critical Illness
University Hospital Birmingham NHS Foundation Trust 124
Early research (Phase 1)UnknownNCT03576014
What this trial is testing

Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient

Who this might be right for
Cytomegalovirus InfectionsPreventation of Cytomegalovirus ReactivationBK Virus Infection+1 more
SL VAXiGEN 18
Not applicableStudy completedNCT02527291
What this trial is testing

Cytomegalovirus Reactivation in Non Immunocompromised Patients Undergoing Cardiac Surgery

Who this might be right for
Cardiac Surgery
Soroka University Medical Center 30
Large-scale testing (Phase 3)Study completedNCT00330018
What this trial is testing

Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)

Who this might be right for
Bone Marrow TransplantationCytomegalovirus
Hadassah Medical Organization 40
Not applicableStudy completedNCT00467532
What this trial is testing

Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients

Who this might be right for
BurnsCytomegalovirus
University of North Carolina, Chapel Hill 60
Not applicableUnknownNCT03210090
What this trial is testing

Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients

Who this might be right for
Cytomegalovirus InfectionHSCT
Maimónides Biomedical Research Institute of Córdoba 100
Not applicableLooking for participantsNCT04030676
What this trial is testing

QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis

Who this might be right for
Cytomegalovirus Infections
Centre Hospitalier Universitaire de Saint Etienne 196
Not applicableStudy completedNCT05419206
What this trial is testing

The Relationship Between CMV* Reactivation and Anti-cytokine Treatment in Critical COVID-19 Patients

Who this might be right for
COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality
Ramazan Gozukucuk 167
Testing effectiveness (Phase 2)UnknownNCT01633476
What this trial is testing

CMV Modulation of the Immune System in ANCA-associated Vasculitis

Who this might be right for
ANCA Associated VasculitisCMV Infection
Professor Lorraine Harper 38
Testing effectiveness (Phase 2)Study completedNCT01063829
What this trial is testing

Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients

Who this might be right for
HCMV Reactivation or HCMV End-Organ Disease
AiCuris Anti-infective Cures AG 133
Not applicableUnknownNCT06362720
What this trial is testing

The Comparison the CMV Infection and Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Between Standard Regimen, Methotrexate Plus Cyclosporin A, and Post-transplant Cyclophosphamide-based Regimen

Who this might be right for
CMV Infection or Reactivation After Allogenic HSCT
Siriraj Hospital 158
Testing effectiveness (Phase 2)Looking for participantsNCT06572462
What this trial is testing

ATG Individualized Dosing Model in URD-PBSCT.

Who this might be right for
Cytomegalovirus InfectionsInfection ReactivationStem Cell Transplant Complications
Chinese PLA General Hospital 30
Not applicableStudy completedNCT00091884
What this trial is testing

Efficacy of Elevated CD4 Counts on CMV Retinitis

Who this might be right for
Acquired Immunodeficiency SyndromeCytomegalovirus Retinitis
National Eye Institute (NEI) 15
Post-approval studies (Phase 4)UnknownNCT05914675
What this trial is testing

Letermovir for Primary Prophylaxis of Cytomegalovirus Infection After R+HID-HSCT

Who this might be right for
The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
Institute of Hematology & Blood Diseases Hospital, China 21